Cooperative Agreement NU01PS003327

The U.S. Agency for International Development (USAID) awarded a 3-year, $500,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to support medical licensing reforms in Vietnam. The project, led by Brigham & Women's Hospital Inc. with sub-award partner Beth Israel Deaconess Medical Center, Inc. (Bidmc), aims to build the capacity of Vietnamese universities and medical institutions to develop, validate, and implement a new national...

The Commonwealth of Virginia State Board of Health, Office of Epidemiology, was awarded a $1,267,208 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Tuberculosis Elimination and Laboratory Cooperative Agreement program (CFDA 93.940) to support a comprehensive public health initiative to control, prevent, and eventually eliminate tuberculosis (TB) in Virginia. The funding will be used to: (1) diagnose and treat active TB cases, (2) conduct contact...

This federal Project Grant award of $1,251,718 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support the "Heart and Lung Outcomes Post-TB (HALO POST-TB)" study. The study aims to elucidate the prevalence, trajectory, and mechanisms of cardiopulmonary abnormalities following tuberculosis (TB), as well as examine the role of HIV coinfection as a potential effect modifier. The research will enroll 480...

This $212,636 Project Grant awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop tools to facilitate tuberculosis (TB) preventive therapy for children and adolescents in primary care settings in low- and middle-income countries. The key products or services to be delivered include: 1) deriving a risk score to predict chest X-ray abnormalities among child and adolescent...

This Project Grant award from the John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) will provide $559,341 over 5 years to support research aimed at improving the diagnosis and treatment of tuberculosis (TB) in children under 5 years old in Malawi. The award recipient is a partnership between Henry Ford Health and Michigan State University Health Sciences, with Michigan State University serving as the parent organization. The key products and...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to characterize the burden, severity, and phenotypic presentation of post-tuberculosis (TB) lung disease (PTLD) and its association with interleukin-6 (IL-6) signaling pathways in TB patients with and without HIV. The total funding amount is $743,698.00 over the award period from Sep 20, 2024 to Aug 31, 2029. The grant will leverage an...

This three-year, $2.97 million Project Grant from the National Institutes of Health's Trans-NIH Research Support program will support the development of a novel lung research platform to probe pulmonary (patho)physiology in real-time at the cellular level. Trustees of Boston University will receive funding to create the LungEx platform, which includes long-term ex vivo maintenance of mouse and human lungs under near-physiological conditions. A key innovation is a "Crystal" ribcage that...

This $8.7 million project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports the development of patient care technologies for permanent ambulatory artificial lung support from May 2022 to April 2026. Carnegie Mellon University is the primary awardee and will develop technologies to transition a pulmonary assist system to long-term support of chronic lung disease patients. Vanderbilt University Medical...

This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $639,615 to the University of California, Los Angeles (UCLA) to adapt and pilot test an evidence-based intervention, called Transaction (TA), for transgender women (TW) in Vietnam. The research team, including collaborators from the Friends Research Institute, will work with TW community-based organizations in Vietnam to develop the adapted TA...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is funding research to develop novel host-directed therapies (HDTs) using pro-apoptotic drugs as an adjunct treatment for pulmonary tuberculosis (TB). The $774,881 award will support the development of HDT approaches to shorten TB treatments, prevent post-TB lung disease, and improve antibiotic penetration into TB lesions. The...